Rivastigmine improves dual-task gait velocity in patients with Alzheimer ’s disease

Gait impairments are common in patients with Alzheimer ’s disease. Cholinesterase inhibitors are used to treat the symptoms of patients with Alzheimer’s disease, but they have not been shown to reduce the sever...

Source: BMC Neurology - February 10, 2021 Category: Neurology Authors: Hideki Shimura, Aiba Saiko, Akito Hayashi, Nobutaka Hattori and Takao Urabe Tags: Research article Source Type: research